| Fcγ receptors as regulators of immune responses F Nimmerjahn, JV Ravetch Nature Reviews Immunology 8 (1), 34-47, 2008 | 3405 | 2008 |
| Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation Y Kaneko, F Nimmerjahn, JV Ravetch science 313 (5787), 670-673, 2006 | 2118 | 2006 |
| Fcγ receptors: old friends and new family members F Nimmerjahn, JV Ravetch Immunity 24 (1), 19-28, 2006 | 1401 | 2006 |
| Divergent immunoglobulin g subclass activity through selective Fc receptor binding F Nimmerjahn, JV Ravetch Science 310 (5753), 1510-1512, 2005 | 1310 | 2005 |
| Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc RM Anthony, F Nimmerjahn, DJ Ashline, VN Reinhold, JC Paulson, ... Science 320 (5874), 373-376, 2008 | 962 | 2008 |
| FcγRIV: a novel FcR with distinct IgG subclass specificity F Nimmerjahn, P Bruhns, K Horiuchi, JV Ravetch Immunity 23 (1), 41-51, 2005 | 884 | 2005 |
| Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin U Harre, D Georgess, H Bang, A Bozec, R Axmann, E Ossipova, ... The Journal of clinical investigation 122 (5), 1791-1802, 2012 | 858 | 2012 |
| Intravenous immunoglobulin therapy: how does IgG modulate the immune system? I Schwab, F Nimmerjahn Nature Reviews Immunology 13 (3), 176-189, 2013 | 856 | 2013 |
| Anti-inflammatory actions of intravenous immunoglobulin F Nimmerjahn, JV Ravetch Annu. Rev. Immunol. 26 (1), 513-533, 2008 | 666 | 2008 |
| Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate H Schoenen, B Bodendorfer, K Hitchens, S Manzanero, K Werninghaus, ... The Journal of Immunology 184 (6), 2756-2760, 2010 | 542 | 2010 |
| Fc‐receptors as regulators of immunity F Nimmerjahn, JV Ravetch Advances in immunology 96, 179-204, 2007 | 532 | 2007 |
| Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1 CM Karsten, MK Pandey, J Figge, R Kilchenstein, PR Taylor, M Rosas, ... Nature medicine 18 (9), 1401-1406, 2012 | 495 | 2012 |
| Mechanisms of autoantibody-induced pathology RJ Ludwig, K Vanhoorelbeke, F Leypoldt, Z Kaya, K Bieber, ... Frontiers in immunology 8, 603, 2017 | 453 | 2017 |
| Major histocompatibility complex class II‐restricted presentation of a cytosolic antigen by autophagy F Nimmerjahn, S Milosevic, U Behrends, EM Jaffee, DM Pardoll, ... European journal of immunology 33 (5), 1250-1259, 2003 | 386 | 2003 |
| Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ–Syk–Card9–dependent innate immune activation K Werninghaus, A Babiak, O Groß, C Hölscher, H Dietrich, EM Agger, ... Journal of Experimental Medicine 206 (1), 89-97, 2009 | 367 | 2009 |
| The antiinflammatory activity of IgG: the intravenous IgG paradox F Nimmerjahn, JV Ravetch The Journal of experimental medicine 204 (1), 11-15, 2007 | 354 | 2007 |
| Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease R Pfeifle, T Rothe, N Ipseiz, HU Scherer, S Culemann, U Harre, ... Nature immunology 18 (1), 104-113, 2017 | 341 | 2017 |
| Antibody‐mediated modulation of immune responses F Nimmerjahn, JV Ravetch Immunological reviews 236 (1), 265-275, 2010 | 331 | 2010 |
| Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity F Nimmerjahn, RM Anthony, JV Ravetch Proceedings of the National Academy of Sciences 104 (20), 8433-8437, 2007 | 324 | 2007 |
| Antibodies, Fc receptors and cancer F Nimmerjahn, JV Ravetch Current opinion in immunology 19 (2), 239-245, 2007 | 323 | 2007 |
Jeffrey RavetchRockefeller University在 rockefeller.edu 的电子邮件经过验证
